Women Engaging in Quitting Smoking Together

• Status: Completed
• Trial end date: 2018-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The long-term goal of this program of research is to develop and disseminate an efficacious, group-based distress tolerance treatment for weight concern (DT-W) that will significantly increase smoking cessation rates among women. The objective of this project is to conduct a preliminary randomized controlled trial (RCT) (N = 60) comparing DT-W to a Health Education (HE) comparison intervention, in which both groups also receive standard behavioral smoking cessation treatment (ST) including counseling and transdermal nicotine patch (TNP), and examine potential mechanisms that may underlie the efficacy of DT-W in improving smoking outcomes at 1-, 3-, and 6-month follow-ups.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rhode Island Hospital
• Collaborator: National Institute on Drug Abuse (NIDA)
• Treatments: Nicotine

Criteria

Inclusion Criteria:

female

• at least 18 years of age

• smoke 5 or more cigarettes per day

• daily smoker for at least the past year

• report motivation to quit smoking in the next month of at least 5 on a 10 point scale

• report concern of at least 50 on at least one of two 100 point scales assessing weight concern

• able to travel to study location for study appointments

Exclusion Criteria:

• current use of other smoking cessation or weight loss therapies

• current use of other tobacco products at least weekly

• diagnosis or treatment for non-nicotine substance use disorder with substance use during the past 6 months

• lifetime diagnosis or treatment of eating disorder, bipolar disorder, schizophrenia, or schizoaffective disorder

• score above established cut-offs on self-report screening measures of depressive symptomology, eating disorder symptomology, alcohol use disorder, or drug use disorder

• current suicidality or homicidality

• medical condition that is a contraindication for the use of transdermal nicotine patch

• lives at same address as current or past participant